FreeGulliver LLC Grows Stock Holdings in The Oncology Institute, Inc. (NASDAQ:TOI)

FreeGulliver LLC lifted its stake in The Oncology Institute, Inc. (NASDAQ:TOI) by 219.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 600,747 shares of the company’s stock after purchasing an additional 412,578 shares during the quarter. FreeGulliver LLC owned about 0.80% of Oncology Institute worth $186,000 as of its most recent SEC filing.

Separately, HighTower Advisors LLC boosted its stake in Oncology Institute by 190.8% in the 3rd quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock worth $27,000 after purchasing an additional 53,382 shares in the last quarter. 36.86% of the stock is owned by institutional investors.

Oncology Institute Stock Up 18.1 %

TOI stock opened at $0.83 on Wednesday. The firm has a 50 day moving average of $0.74 and a 200 day moving average of $0.44. The stock has a market capitalization of $62.54 million, a PE ratio of -1.06 and a beta of 0.41. The company has a quick ratio of 2.27, a current ratio of 2.49 and a debt-to-equity ratio of 5.91. The Oncology Institute, Inc. has a 52 week low of $0.13 and a 52 week high of $1.89.

Oncology Institute Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.